Results 31 to 40 of about 16,231 (238)

Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome mimicking symptoms of polymyalgia rheumatica: a case report

Journal of Medical Case Reports, 2022
Background Remitting seronegative symmetrical synovitis with pitting edema is a rare rheumatic condition of the elderly population that is well described but whose mechanisms remain little studied.
Katarzyna Tarasiuk-Stanislawek, Alexandre Dumusc, Bernard Favrat, Ioannis Kokkinakis   +3 more
doaj   +1 more source

2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative [PDF]

, 2017
Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international recommendations for PMR treatment are not currently available.
Abril, Andy, Bachta, Artur, Balint, Peter, Barraclough, Kevin, Bianconi, Lina, Buttgereit, Frank, Camellino, Dario, Carsons, Steven, Ching, Daniel, Cid Xutglà, M. Cinta, Cimmino, Marco A., Dasgupta, Bhaskar, Dejaco, Christian, Diamantopoulos, Andreas P., Docken, William, Duftner, Christina, Fashanu, Billy, Gilbert, Kate, Hildreth, Pamela, Hollywood, Jane, Hutchings, Andrew, Jayne, David, Lima, Manuella, Mackie, Sarah L., Maharaj, Ajesh, Mallen, Christian, Martínez Taboada, Víctor Manuel, Matteson, Eric L, Maz, Mehrdad, Merry, Steven, Miller, Jean, Mori, Shunsuke, Neill, Lorna, Nordborg, Elisabeth, Nott, Jenifer, Padbury, Hannah, Pease, Colin, Perel, Pablo, Salvarani, Carlo, Schirmer, Michael, Schmidt, Wolfgang, Singh, Yogesh P., Spiera, Robert, Tronnier, David, Wagner, Alexandre, Whitlock, Madeleine   +45 more
core   +1 more source

Giant cell temporal arteritis associated with overlying basal cell carcinoma: co-incidence or connection?

Rare Tumors, 2012
Giant cell arteritis is a granulomatous vasculitis of large and medium sized arteries manifesting as temporal arteritis and/or polymyalgia rheumatica.
Salem Alowami, Anita Bane, Dina El Demellawy, Etienne Mahe   +3 more
doaj   +1 more source

"An Impediment to Living Life": Why and How Should We Measure Stiffness in Polymyalgia Rheumatica? [PDF]

, 2015
Objectives: To explore patients’ concepts of stiffness in polymyalgia rheumatica (PMR), and how they think stiffness should be measured. Methods: Eight focus groups were held at three centres involving 50 patients with current/previous PMR.
A Hutchings, B Dasgupta, B Dasgupta, BF Leeb, CC Ruff, Colin Pease, EL Matteson, J Carpenter, JM Hazes, John Day, John Kirwan, JR Kirwan, JS Creswell, M Boers, M De Wit, Margaret Walsh, Marianne Morris, Marion Newton, R Spiera, Rodney Hughes, S Hewlett, S Kalke, S Wilkinson, Sam Eldabe, Sarah Louise Mackie, SE Gabriel, SL Mackie, SL Mackie, V Braun, Vlieland TP Vleit   +29 more
core   +3 more sources

Polymyalgia Rheumatica (PMR) Special Interest Group at OMERACT 11: outcomes of importance for patients with PMR [PDF]

, 2014
We worked toward developing a core outcome set for clinical research studies in polymyalgia rheumatica (PMR) by conducting (1) patient consultations using modified nominal group technique; (2) a systematic literature review of outcome measures in PMR; (3)
Sarah L. Mackie, Seher Arat, Jose da Silva, Catia Duarte, Sue Halliday, Rod Hughes, Marianne Morris, Colin T. Pease, Jeffrey W. Sherman, Lee S. Simon, Maggie Walsh, René Westhovens, Samy Zakout, John R. Kirwan, Dasgupta, Minnock, Zakout   +16 more
core   +2 more sources

Polymyalgia rheumatica in the 2018–2020 clinical guidelines. Part I. At-risk groups, adjuvant therapy

Bolʹ, Sustavy, Pozvonočnik, 2020
At the beginning of the Healthy Ageing Decade, a number of guidelines were published describing management of the rheumatic diseases of the elderly. The aim of the paper is to cha­racterize and discuss the Italian Society of Rheumatology’s guideline for ...
О.G. Puzanovа
doaj   +1 more source

REVIEW OF RECOMMENDATIONS FOR THE MANAGEMENT OF POLYMYALGIA RHEUMATICA (ACR/EULAR 2015)

Архивъ внутренней медицины, 2016
Recommendations for the management of polymyalgia rheumatica are reflected in presented translation of new international guidelines (ACR/EULAR 2015).
M. T. Vatutin, G. S. Smyrnova, G. G. Taradin, M. A. El-Khatib   +3 more
doaj   +1 more source

The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population [PDF]

, 2016
Background: To update community-based prevalence values for Polymyalgia Rheumatic (PMR) and Giant Cell Arteritis (GCA) using case record review supplemented by population survey and subsequent clinical review.
A Mohammad, Alexander James MacGregor, B Baslund, B Dasgupta, C Salvarani, DP Symmons, F Borg, F Salaffi, GG Hunder, HA Bird, HS Barber, J Ninan, JG Jones, K Herlyn, Karly Graham, L Smeeth, LA Healey, Max Yates, MF Doran, ON Pamuk, P Macchioni, RA Watts, RC Lawrence, Richard Arthur Watts, S Bernatsky, S Kobayashi, T Helliwell, T Loddenkemper, TY Chuang, V Kyle, W Bruce   +30 more
core   +1 more source

Is cancer associated with polymyalgia rheumatica?: A cohort study in the General Practice Research Database [PDF]

, 2013
OBJECTIVE: To investigate the incidence of new cancer diagnoses in a community sample of patients with polymyalgia rheumatica (PMR). METHODS: All incident cases of PMR in the UK General Practice Research Database (GPRD) (1987-99), without pre-existing ...
Belcher, J, Helliwell, T, Hider, SL, Mallen, CD, Muller, S   +4 more
core   +1 more source

Polymyalgia rheumatica: concerted efforts of the European rheumatological societies

Bolʹ, Sustavy, Pozvonočnik, 2020
Population’s ageing is a prerequisite for a strengthened evidence base of the specific geriatric syndromes, late-onset rheumatic diseases, and rheumatic diseases of the elderly.
О.G. Puzanova, Yu.О. Moshkovska, V.О. Sobol   +2 more
doaj   +1 more source